Company News
Now that Alnylam Pharmaceuticals Inc’s volume has hit 0.75 million, investors get a glimpse of its size.
On Friday, Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) was -3.19% drop from the session before settling in for the closing price of $264.89. A 52-week range
